Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
ClearPoint Neuro, Inc.February 18, 2021 GMT
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a worldwide license and research agreement with Philips, a global leader in health technology, to commercialize the ClearPoint ‘Maestro’ Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022.